HCA Healthcare (NYSE:HCA) EVP Michael Mcalevey Sells 3,892 Shares

HCA Healthcare, Inc. (NYSE:HCA) EVP Michael Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

HCA Healthcare Stock Up 0.3%

Shares of HCA Healthcare stock opened at $472.97 on Thursday. The firm has a market cap of $107.93 billion, a PE ratio of 18.28, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $478.19. The company’s fifty day simple moving average is $425.01 and its two-hundred day simple moving average is $389.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Analysts Set New Price Targets

HCA has been the topic of several recent analyst reports. Mizuho lifted their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a report on Monday, October 27th. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Robert W. Baird upped their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Finally, Bank of America upped their price objective on HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $473.53.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $26,000. Saudi Central Bank bought a new stake in HCA Healthcare during the first quarter valued at about $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare during the first quarter valued at about $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the 2nd quarter valued at approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.